Zydus Lifesciences Ltd has received the EIR report from the USFDA for the inspection conducted at its API manufacturing facility located at Ambernath, Maharashtra. This facility underwent an inspection from 10th to 14th February 2025, and had ended with NIL observations. The EIR report has classified it as No Action Indicated (NAI).
Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 904.00 as compared to the previous close of Rs. 901.65. The total number of shares traded during the day was 15562 in over 1684 trades.
The stock hit an intraday high of Rs. 909.40 and intraday low of 891.00. The net turnover during the day was Rs. 14008739.00.